CD274 and neoplasm: It is suggested that PD-L1 CDx plays an important role in guiding the use of antibody in tumour immunotherapy, improving the accuracy of tumour pathological detection and prognostic assessment, and the development of PD-L1 CDx reagents is the inevitable trend of immune checkpoint targeted therapy in the future.